146 related articles for article (PubMed ID: 30337049)
1. [Results of a retrospective study on radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma].
Ghorbal L; Hdiji A; Ben Salah H; Elloumi F; Frikha M; Elloumi M; Daoud J
Cancer Radiother; 2018 Dec; 22(8):763-766. PubMed ID: 30337049
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Abe S; Oda I; Inaba K; Suzuki H; Yoshinaga S; Nonaka S; Morota M; Murakami N; Itami J; Kobayashi Y; Maeshima AM; Saito Y
Jpn J Clin Oncol; 2013 Sep; 43(9):917-22. PubMed ID: 23878345
[TBL] [Abstract][Full Text] [Related]
3. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
[TBL] [Abstract][Full Text] [Related]
4. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
5. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
Ruskoné-Fourmestraux A; Matysiak-Budnik T; Fabiani B; Cervera P; Brixi H; Le Malicot K; Nion-Larmurier I; Fléjou JF; Hennequin C; Quéro L;
Radiother Oncol; 2015 Oct; 117(1):178-82. PubMed ID: 26395311
[TBL] [Abstract][Full Text] [Related]
6. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.
Schmelz R; Miehlke S; Thiede C; Brueckner S; Dawel M; Kuhn M; Ruskoné-Formestraux A; Stolte M; Jentsch C; Hampe J; Morgner A
J Gastroenterol; 2019 May; 54(5):388-395. PubMed ID: 30327875
[TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy for localized gastric and orbital MALT lymphomas].
Quéro L; Hennequin C; Amorim S; Guillerm S; Ruskoné-Fourmestraux A; Thieblemont C
Cancer Radiother; 2016 Oct; 20(6-7):543-6. PubMed ID: 27614509
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
9. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
[TBL] [Abstract][Full Text] [Related]
11. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
12. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
13. Gastric mucosa-associated lymphoid tissue lymphoma: radiographic findings in six patients.
Yoo CC; Levine MS; Furth EE; Salhany KE; Rubesin SE; Laufer I; Herlinger H
Radiology; 1998 Jul; 208(1):239-43. PubMed ID: 9646819
[TBL] [Abstract][Full Text] [Related]
14. [Clinical Efficacy of Radiotherapy in
Park BS; Lee SH
Korean J Gastroenterol; 2019 Jan; 73(1):19-25. PubMed ID: 30690954
[TBL] [Abstract][Full Text] [Related]
15. Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Komoto M; Tominaga K; Nakata B; Takashima T; Inoue T; Hirakawa K
J Exp Clin Cancer Res; 2006 Jun; 25(2):283-5. PubMed ID: 16918142
[TBL] [Abstract][Full Text] [Related]
16. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
17. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
19. Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment.
Fung CY; Grossbard ML; Linggood RM; Younger J; Flieder A; Harris NL; Graeme-Cook F
Cancer; 1999 Jan; 85(1):9-17. PubMed ID: 9921968
[TBL] [Abstract][Full Text] [Related]
20. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
Morgner A; Miehlke S; Fischbach W; Schmitt W; Müller-Hermelink H; Greiner A; Thiede C; Schetelig J; Neubauer A; Stolte M; Ehninger G; Bayerdörffer E
J Clin Oncol; 2001 Apr; 19(7):2041-8. PubMed ID: 11283137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
